SynbiCITE 2.0
- Funded by UK Research and Innovation (UKRI)
- Total publications:11 publications
Grant number: EP/S001859/1
Grant search
Key facts
Disease
COVID-19Start & end year
20182023Known Financial Commitments (USD)
$3,752,487.47Funder
UK Research and Innovation (UKRI)Principal Investigator
PendingResearch Location
United KingdomLead Research Institution
Imperial College LondonResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
Innovation
Study Subject
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Synthetic biology workflows drive higher throughput testing. The approach, led by SynbiCITE Co-Director Professor Paul Freemont, originates from the flexible and adaptable nature of automated synthetic biology workflows. Using the 'design, build, test, learn' approach that is fundamental to synthetic biology, Professor Freemont and a team from the Dementia Research Institute and Imperial College London, used the London BioFoundry's Felix robots to design new workflows to carry out COVID-19 antigen testing using the standard PCR.
Publicationslinked via Europe PMC
Last Updated:3 days ago
View all publications at Europe PMC